X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (301) 301
humans (291) 291
index medicus (174) 174
ovarian cancer (125) 125
middle aged (120) 120
ovarian neoplasms - pathology (120) 120
oncology (105) 105
aged (95) 95
adult (94) 94
cancer (87) 87
fallopian-tube (87) 87
animals (75) 75
fallopian tube neoplasms - pathology (75) 75
ovarian neoplasms - genetics (69) 69
pathology (67) 67
immunohistochemistry (66) 66
fallopian tube (64) 64
ovarian neoplasms - drug therapy (63) 63
fallopian tubes - pathology (52) 52
ovarian neoplasms - metabolism (51) 51
obstetrics & gynecology (49) 49
biochemistry & molecular biology (47) 47
expression (47) 47
tumors (47) 47
biomarkers, tumor - analysis (45) 45
cell biology (45) 45
mutation (45) 45
article (43) 43
carcinoma (43) 43
chemotherapy (41) 41
fallopian tubes - chemistry (41) 41
aged, 80 and over (37) 37
fallopian tube neoplasms - chemistry (37) 37
ovarian neoplasms - chemistry (36) 36
fallopian tube neoplasms - drug therapy (34) 34
mice (34) 34
carcinoma, ovarian epithelial (32) 32
cell line, tumor (32) 32
fallopian tube neoplasms - genetics (32) 32
research (32) 32
female genital diseases and pregnancy complications (29) 29
genetic aspects (28) 28
health aspects (28) 28
breast-cancer (27) 27
cystadenocarcinoma, serous - pathology (27) 27
endocrine system diseases (27) 27
neoplasm staging (27) 27
peritoneal neoplasms - drug therapy (27) 27
gene expression regulation, neoplastic (26) 26
neoplasm grading (26) 26
ovarian carcinoma (26) 26
prognosis (26) 26
women (26) 26
cells (24) 24
diagnosis (24) 24
fallopian tubes - metabolism (24) 24
gene expression (24) 24
neoplasms, glandular and epithelial - pathology (23) 23
ovary (23) 23
treatment outcome (23) 23
biology (22) 22
care and treatment (22) 22
development and progression (22) 22
fallopian tubes - surgery (22) 22
research article (22) 22
surgery (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
medicine (21) 21
ovariectomy (21) 21
review (21) 21
breast cancer (20) 20
disease-free survival (20) 20
cystadenocarcinoma, serous - genetics (19) 19
hematology, oncology and palliative medicine (19) 19
metastasis (19) 19
analysis (18) 18
genetics & heredity (18) 18
intraepithelial carcinoma (18) 18
neoplasms, glandular and epithelial - drug therapy (18) 18
obstetrics and gynecology (18) 18
serous carcinoma (18) 18
epithelium (17) 17
fallopian tubes (17) 17
genetic predisposition to disease (17) 17
ovarian neoplasms - diagnosis (17) 17
ovarian-cancer (17) 17
ovary - pathology (17) 17
survival (17) 17
apoptosis (16) 16
carcinogenesis (16) 16
cell proliferation (16) 16
epithelium - pathology (16) 16
medicine, research & experimental (16) 16
ovarian neoplasms - mortality (16) 16
pathogenesis (16) 16
peritoneal neoplasms - pathology (16) 16
pregnancy (16) 16
proteins (16) 16
adenocarcinoma (15) 15
endocrine system (15) 15
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (308) 308
Russian (4) 4
Chinese (2) 2
French (1) 1
German (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Pathology, ISSN 0893-3952, 08/2015, Volume 28, Issue 8, pp. 1101 - 1122
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 09/2017, Volume 146, Issue 3, pp. 484 - 490
Indoleamine 2,3-dioxygenase-1 (IDO1) is a key regulator of immune tolerance in ovarian cancer. This study investigated efficacy and safety of the IDO1 enzyme... 
Epacadostat | IDO1 enzyme inhibitor | Tamoxifen | Ca-125 | Ovarian cancer | SURVIVAL | DIAGNOSIS | PROTEIN | PROGNOSIS | INDOLEAMINE 2,3-DIOXYGENASE | OBSTETRICS & GYNECOLOGY | ONCOLOGY | IMMUNOTHERAPY | EXPRESSION | T-CELLS | Recurrence | Neoplasms, Glandular and Epithelial - chemistry | Oximes - pharmacokinetics | Oximes - adverse effects | Peritoneal Neoplasms - blood | Humans | Middle Aged | Oximes - therapeutic use | Response Evaluation Criteria in Solid Tumors | Fatigue - chemically induced | Peritoneal Neoplasms - chemistry | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Fallopian Tube Neoplasms - blood | Neoplasms, Glandular and Epithelial - blood | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - chemistry | Exanthema - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Ovarian Neoplasms - drug therapy | Pruritus - chemically induced | Fallopian Tube Neoplasms - drug therapy | Drug Eruptions - etiology | Ovarian Neoplasms - chemistry | CA-125 Antigen - blood | Indoleamine-Pyrrole 2,3,-Dioxygenase - analysis | Ovarian Neoplasms - blood | Survival Rate | Sulfonamides - pharmacokinetics | Disease-Free Survival | Sulfonamides - therapeutic use | Tamoxifen - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Sulfonamides - adverse effects | Aged | Tamoxifen - adverse effects | Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors | Care and treatment | Chemotherapy | Enzyme inhibitors | Cancer | Medical research | Medicine, Experimental
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 10, pp. 1112 - 1118
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 08/2013, Volume 37, Issue 8, pp. 1123 - 1130
Pelvic serous carcinoma is usually advanced stage at diagnosis, indicating that abdominal spread occurs early in carcinogenesis. Recent discovery of a... 
ovary | serous cancer | fallopian tube | metastasis | shedding | intraluminal | STIC | SURGERY | PROPHYLACTIC OOPHORECTOMY SPECIMENS | HIGH-RISK WOMEN | MUTATION CARRIERS | FOLLOW-UP | PATHOLOGICAL FINDINGS | PATHOLOGY | INTRAEPITHELIAL CARCINOMA | SEROUS CARCINOMA | SALPINGO-OOPHORECTOMY | HEREDITARY OVARIAN-CANCER | SUSPECTED BRCA-1 | Immunohistochemistry | Abdominal Neoplasms - secondary | Carcinoma in Situ - chemistry | Neoplasms, Cystic, Mucinous, and Serous - surgery | Prognosis | PAX2 Transcription Factor - analysis | Humans | Middle Aged | Neoplasms, Cystic, Mucinous, and Serous - secondary | Tumor Suppressor Protein p53 - genetics | Neoplasms, Cystic, Mucinous, and Serous - genetics | Tumor Suppressor Protein p53 - analysis | Abdominal Neoplasms - chemistry | Carcinoma in Situ - genetics | Carcinoma in Situ - surgery | Fallopian Tube Neoplasms - chemistry | DNA Mutational Analysis | Fallopian Tube Neoplasms - genetics | Adult | Female | Precancerous Conditions - pathology | Neoplasms, Cystic, Mucinous, and Serous - chemistry | WT1 Proteins - analysis | Ovariectomy | Biomarkers, Tumor - analysis | Carcinoma in Situ - pathology | Neoplasm Invasiveness | Fallopian Tube Neoplasms - pathology | Salpingectomy | Precancerous Conditions - genetics | Paired Box Transcription Factors - analysis | BRCA1 Protein - genetics | Precancerous Conditions - surgery | Precancerous Conditions - chemistry | Fallopian Tube Neoplasms - surgery | Abdominal Neoplasms - genetics | Aged | Biomarkers, Tumor - genetics | Mutation | PAX8 Transcription Factor | Index Medicus
Journal Article
Journal Article
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 06/2014, Volume 38, Issue 6, pp. 729 - 742
Journal Article
Journal Article
Journal Article
Turk patoloji dergisi, 2017, Volume 1, Issue 1, p. 247
We describe an unusual case of a Peutz-Jeghers syndrome associated with a composite synchronous cervical neoplasia comprising precursor "lobular endocervical... 
Immunohistochemistry | Adenocarcinoma - pathology | Peutz-Jeghers Syndrome - pathology | Humans | Precancerous Conditions - metabolism | Tomography, X-Ray Computed | Uterine Cervical Neoplasms - pathology | Endometrial Hyperplasia - pathology | Neoplasms, Cystic, Mucinous, and Serous - genetics | Young Adult | Neoplasms, Multiple Primary - therapy | Endometrial Hyperplasia - metabolism | Neoplasm Grading | Fallopian Tube Neoplasms - chemistry | Fallopian Tube Neoplasms - genetics | Female | Precancerous Conditions - pathology | Adenocarcinoma - genetics | Endometrial Hyperplasia - therapy | Radiotherapy, Adjuvant | Adenocarcinoma - chemistry | Neoplasms, Cystic, Mucinous, and Serous - chemistry | Uterine Cervical Neoplasms - therapy | Neoplasms, Cystic, Mucinous, and Serous - pathology | Neoplasms, Multiple Primary - genetics | Precancerous Conditions - therapy | Biomarkers, Tumor - analysis | Endometrial Hyperplasia - genetics | Fallopian Tube Neoplasms - pathology | Treatment Outcome | Hysterectomy | Neoplasms, Multiple Primary - pathology | Peutz-Jeghers Syndrome - genetics | Uterine Cervical Neoplasms - genetics | Precancerous Conditions - genetics | Magnetic Resonance Imaging | Neoplasms, Cystic, Mucinous, and Serous - therapy | Adenocarcinoma - therapy | Biopsy | Peutz-Jeghers Syndrome - metabolism | Neoplasms, Multiple Primary - chemistry | Biomarkers, Tumor - genetics | Uterine Cervical Neoplasms - chemistry | Fallopian Tube Neoplasms - therapy
Journal Article
International Journal of Gynecological Pathology, ISSN 0277-1691, 11/2012, Volume 31, Issue 6, pp. 517 - 523
Journal Article
Journal Article